Robustly Validate the Clinical Utility of Microbial Therapeutics

Maximizing Investment Through Robust Translation, Clinical Data & GMP Manufacturing Efficiency

Calling All Start-Ups!

Apply to the Start-Up Showcase to present your preclinical pipeline
to the entire audience & expert investor panel and access
a discounted start-up price!

Welcome to the 9th Microbiome Movement Drug Development Summit

The Home of Accelerating Microbial-Based Drug Development

As landmark Ferring & Seres Therapeutics approvals prove the safety of the microbiome modality, robust clinical efficacy data for disease beyond infectious is now paramount to reinvigorate investment across the community.

The 9th Microbiome Movement Drug Development Summit returns as the industry’s trusted, definitive forum for the global network of microbial therapeutic developers. It ensures teams can stay ahead of the curve to robustly prove clinical efficacy as regulator and investor scrutiny necessitates more compelling data than ever before.

Your only meeting dedicated to supporting business-critical networking, featuring a start-up showcase to connect the ecosystem, this is an unmissable touchpoint for developers to gain insights from pipelines generating robust data in the clinic and improve your navigation of a fast-evolving market landscape.

Across 2 conference days, with Translational, Clinical & Manufacturing tracks, and an additional 4 deep-dive workshops & a Focus Day designed for innovation scouting and networking, join C-Level and Investor stakeholders, as 250+ innovators and thought-leaders gather under the common goal to prove the power of microbiome modalities!

Be part of the industry’s premier platform for connection-building in 2024 and shape the future direction of the microbiome-altering therapeutics field!


Access the comprehensive agenda, speaker line-up, and
pre-conference day

A Snapshot of Your 45+ Expert Speaking Faculty:

Welcoming New Organizations in 2024, Including:

Companies in the Room: FTI, Endure Bio, MD Anderson Cancer Center, Bill & Melinda Gates Foundation, Gusto Global
Companies in the Room: Exegi Pharma, Merck, MHRA, MRM Health & ADM
mCompanies in the Room: Yakult, Piton Therapeutics, Myota, Vedanta, Rise Therapeutics
Companies in the Room: Freya, Ilya Pharma, Maat, Endure Bio, AOBiome, Microbiotica

“For me the Microbiome Movement Drug Development Summit is the best conference in the microbiome space to stay informed of the latest developments in this exciting industry”

Daniel Van de Leile, Chief Executive Officer & Chief Scientific Officer, Gusto Global

What To Expect:








Hours of


Deep Dive Pipeline Strategy Workshops


Bioconvergence Focus Day

2024 Partners Include:

Lead Partner:

2024 Partner - Biose

Expertise Partners:

BA_Final Logo 2024 (3) (1)

Program Partners:

2024 Partner - List Labs
2024 Partner - One Codex
Sacco System
2024 Partner - Wacker

Exhibition Partners:

2024 Partner - Bacthera
2024 Partner - EzBiome
SGS Quay Pharma
2024 Partner - Anaerobe Systems

Event Partners: